These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


574 related items for PubMed ID: 14975475

  • 1. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
    Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC.
    J Am Coll Cardiol; 2004 Feb 18; 43(4):635-41. PubMed ID: 14975475
    [Abstract] [Full Text] [Related]

  • 2. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
    Cournot M, Mourre F, Castel F, Ferrières J, Destrac S.
    Am Heart J; 2008 Jun 18; 155(6):986-91. PubMed ID: 18513508
    [Abstract] [Full Text] [Related]

  • 3. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2329-35. PubMed ID: 18549918
    [Abstract] [Full Text] [Related]

  • 4. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.
    Steg PG, Joubin L, McCord J, Abraham WT, Hollander JE, Omland T, Mentré F, McCullough PA, Maisel AS.
    Chest; 2005 Jul 17; 128(1):21-9. PubMed ID: 16002911
    [Abstract] [Full Text] [Related]

  • 5. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L.
    Int J Cardiol; 2010 Apr 01; 140(1):88-94. PubMed ID: 19321212
    [Abstract] [Full Text] [Related]

  • 6. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN, Gemignani A, Ronan A, Vasaiwala S, Blair J, Brennan JM, Shah DP, Spencer KT.
    JACC Cardiovasc Imaging; 2008 Sep 01; 1(5):595-601. PubMed ID: 19356487
    [Abstract] [Full Text] [Related]

  • 7. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.
    Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton P, Maisel A.
    J Am Coll Cardiol; 2001 Feb 01; 37(2):386-91. PubMed ID: 11216951
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R, Aspromonte N, Carbonieri E, De Michele G, Di Tano G, Giovinazzo P, Cioè R, Di Giacomo T, Milani L, Noventa F, Chiatto M.
    Monaldi Arch Chest Dis; 2007 Sep 01; 68(3):154-64. PubMed ID: 18361212
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 13. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L.
    J Card Fail; 2008 Apr 13; 14(3):219-24. PubMed ID: 18381185
    [Abstract] [Full Text] [Related]

  • 14. Significance of predischarge BNP on one-year outcome in decompensated heart failure--comparative study with echo-Doppler indexes.
    Hamada Y, Tanaka N, Murata K, Takaki A, Wada Y, Oyama R, Liu J, Harada N, Okuda S, Hadano Y, Matsuzaki M.
    J Card Fail; 2005 Feb 13; 11(1):43-9. PubMed ID: 15704063
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromes.
    Minami Y, Kajimoto K, Sato N, Hagiwara N, Takano T, Mebazaa A, ATTEND Study Investigators.
    Eur J Intern Med; 2016 Jun 13; 31():41-9. PubMed ID: 26880295
    [Abstract] [Full Text] [Related]

  • 18. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW, Sanders-van Wijk S, van Kraaij DJ, van Kimmenade R, Meeder JG, Kamp O, van Dieijen-Visser MP, Tijssen JG, Brunner-La Rocca HP, Pinto YM.
    J Card Fail; 2014 Dec 13; 20(12):881-90. PubMed ID: 25175696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.
    Omar HR, Guglin M.
    Int J Cardiol; 2016 Oct 15; 221():1116-22. PubMed ID: 27467969
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.